Erector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis
Not Applicable
Not yet recruiting
- Conditions
- Idiopathic ScoliosisErector Spinae Plane BlockPatient Controlled Analgesia
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06728046
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture
Not Applicable
Not yet recruiting
- Conditions
- Hip FracturesUltrasound-guided Nerve BlockPerioperative Analgesia
- Interventions
- Other: supra-inguinal fascia iliaca compartment block
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT06728033
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Artificial Intelligence Prognostic Model for Sepsis Based on Time Series Analysis
Completed
- Conditions
- SepsisPrognostic ModelArtificial IntelligenceIndividuality
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 3641
- Registration Number
- NCT06724120
- Locations
- 🇨🇳
Chi Zhang, Chengdu, Sichuan, China
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Thyroid Gland CarcinomaThyroid Cancer
- Interventions
- Drug: Cyclophosphamide+Pemetrexed+5-FluorouracilDrug: Cyclophosphamide+Doxorubicin+5-Fluorouracil
- First Posted Date
- 2024-12-03
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06713057
- Locations
- 🇨🇳
West China hospital, Chengdu, Sichuan, China
A Nomogram Predicting the Risk of High-dose Transfusion in Non-cardiac Surgery
Completed
- Conditions
- Massive TransfusionNomogram Model
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 11197
- Registration Number
- NCT06701747
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Systematic Oral Education for Prevention of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
Not Applicable
Recruiting
- Conditions
- Malignant Tumor of Head And/or NeckRadiotherapy; Complications
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06690346
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Placebo Response of Different Types of Sham Acupuncture for Knee Osteoarthritis
Not Applicable
Not yet recruiting
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06675981
- Locations
- 🇨🇳
Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China
🇨🇳Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06673290
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Phase 2
Active, not recruiting
- Conditions
- Gastric Adenocarcinoma
- Interventions
- Drug: Chemotherapy plus sintilimab and bevacizumab
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT06667050
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- Interventions
- Radiation: stereotactic body radiation therapy (SBRT)
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT06664996
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
© Copyright 2025. All Rights Reserved by MedPath